IVRE.F Stock Overview
Inovalis REIT is a real estate investment trust listed on the Toronto Stock Exchange in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Inovalis Real Estate Investment Trust Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.79 |
| 52 Week High | CA$2.76 |
| 52 Week Low | CA$0.51 |
| Beta | 1.57 |
| 1 Month Change | -16.89% |
| 3 Month Change | -30.46% |
| 1 Year Change | -69.06% |
| 3 Year Change | -90.34% |
| 5 Year Change | -89.80% |
| Change since IPO | -88.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| IVRE.F | US Office REITs | US Market | |
|---|---|---|---|
| 7D | -0.3% | -2.7% | -3.2% |
| 1Y | -69.1% | 6.2% | 19.3% |
Return vs Industry: IVRE.F underperformed the US Office REITs industry which returned 6.2% over the past year.
Return vs Market: IVRE.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| IVRE.F volatility | |
|---|---|
| IVRE.F Average Weekly Movement | n/a |
| Office REITs Industry Average Movement | 5.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IVRE.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine IVRE.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 300 | Stephane Amine | www.inovalisreit.com |
Inovalis REIT is a real estate investment trust listed on the Toronto Stock Exchange in Canada. It was founded in 2013 by Inovalis and invests in office properties in primary markets of France, Germany and Spain. It holds 13 assets.
Inovalis Real Estate Investment Trust Fundamentals Summary
| IVRE.F fundamental statistics | |
|---|---|
| Market cap | US$27.56m |
| Earnings (TTM) | -US$21.59m |
| Revenue (TTM) | US$14.24m |
1.9x
P/S Ratio-1.2x
P/E RatioIs IVRE.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IVRE.F income statement (TTM) | |
|---|---|
| Revenue | CA$19.58m |
| Cost of Revenue | CA$10.35m |
| Gross Profit | CA$9.23m |
| Other Expenses | CA$38.92m |
| Earnings | -CA$29.69m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.91 |
| Gross Margin | 47.15% |
| Net Profit Margin | -151.62% |
| Debt/Equity Ratio | 47.7% |
How did IVRE.F perform over the long term?
See historical performance and comparison